Zobrazeno 1 - 5
of 5
pro vyhledávání: '"S. V. Gorbatenkova"'
Autor:
D. A. Sychev, K. B. Mirzaev, M. S. Cherniaeva, N. V. Shakhgildyan, Sh. P. Abdullaev, N. P. Denisenko, Zh. A. Sozaeva, A. A. Kachanova, V. R. Shastina, S. V. Gorbatenkova
Publikováno v:
Acta Biomedica Scientifica, Vol 8, Iss 6, Pp 51-80 (2024)
Background. The use of P-glycoprotein (P-gp) inhibitors and carriage of certain ABCB1 polymorphisms can lead to increased concentrations of rivaroxaban and the development of bleeding.The aim of the study. To study the features of drug-drug interacti
Externí odkaz:
https://doaj.org/article/80ceb717f6c74d60a892134e49db667e
Autor:
E. S. Ilina, V. A. Shalygin, D. V. Ivashchenko, M. I. Savelieva, I. I. Sinitsina, S. P. Semenova, S. V. Gorbatenkova, S. N. Puzin, O. T. Bogova, D. A. Sychev
Publikováno v:
Нервно-мышечные болезни, Vol 9, Iss 1, Pp 67-74 (2019)
The article discusses aspects of drug-induced falls in elderly comorbid patients against the background of polypragmasy and also assesses the role of drug interactions that are highly dangerous according to the risk of falling. A drug audit of the ob
Externí odkaz:
https://doaj.org/article/05c467a805594dce93dec57fc1cb0d6b
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 13, Iss 2, Pp 203-206 (2017)
The article presents a case report of 86 years old patient S. (woman), hospitalized in the ophthalmology department of the hospital with a diagnosis of “complicated immature cataract of the left eye, open-angle glaucoma, age-related macular degener
Externí odkaz:
https://doaj.org/article/4d739759dd3a494f994c72b383d99356
Autor:
A. I. Kochetkov, S. V. Batyukina, N. A. Shatalova, V. A. De, I. S. Kulikov, N. A. Arablinsky, N. Yu. Voevodina, V. R. Shastina, S. V. Gorbatenkova, M. S. Chernyaeva, O. D. Ostroumova, D. A. Sychev
Publikováno v:
"Arterial’naya Gipertenziya" ("Arterial Hypertension"). 28:557-572
Background. Arterial hypertension (AH) is often associated with type 2 diabetes mellitus (DM2), is one of the leading modifiable risk factors for cardiovascular disease, atrial fibrillation (AF), chronic kidney disease (CKD). Progression of renal dys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b62545f0da3b3d73e03c4e49ac61e3eb
https://doi.org/10.18705/1607-419x-2022-28-5-557-572
https://doi.org/10.18705/1607-419x-2022-28-5-557-572
Autor:
A.G. Komarova, Dmitriy A. Sychev, O.D. Ostroumova Ostroumova, M.S. Chernyaeva, S. V. Gorbatenkova
Publikováno v:
Siberian Medical Review. :5-13
Admission of certain medications (drugs) can cause the development of atrial fibrillation (AF) in patients having non-evident cardiovascular disease (CVD). Also, it can accelerate the onset of AF in patients with pre-existing CVD. It is important to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d5355ad565b14f16cf6ef8b0c54eadc
https://doi.org/10.20333/2500136-2020-6-5-13
https://doi.org/10.20333/2500136-2020-6-5-13